Lasertyte™ Decollette test
This is an immediate response to re*be's new LaserTyte™ on the Decollette
The before and after photos were taken less than an hour apart.
The rebe clinic is quick to evaluate new treatments and when we feel they will be useful we will offer to treat medically qualified patients. We believe Lasertyte done with a Sicton's Joule™ laser set on pure 1319 infrared energy is penetrating the epidermis into the superficial dermis where it's water chromophore is more abundant. Absorbtion of the water chromophore may be creating enough instant denaturation of the protein collagen matrix to allow shrinkage of the superficial dermis. The equivalent to what happens to bacon when it is cooked. Questions remain as to the long term utility for this procedure but from this experience using it as a 'red carpet' prep as some in Hollywood now rely on our Titan® procedure from Cutera® would clearly be supported. I all of us at re*be® of Okoboji are excited by this test result and anticipate several of our anxious staff will be treated next. Lasertyte™ is trademarked by Hogue Cosmetic Surgery Maple Grove, Minnesota.
Use of Sciton® 1319 to tighten the skin is being investigated in several clinics. re*be is proud to be one location testing this new technique. Watch these results closely and when we are sure this has some utility we will be offerring it to our patients. If you would like to participate now we can add an investigational treatment like Lasertyte™ to the purchase of some other cosmetic procedures at re*be.
The photo to the right is the same upper chest as above immediately after the treatment. The skin is slightly red and clearly edematous smoothing the wrinkles. The immediate effects are obvious and appear to cosmetically enhance the appearance of the skin. The discomfort of heating the skin is well tolerated by the patient. The noticable redness seems to last less than 2 hours. We are not yet able to say how long the changes will last however it looks like they may. Watch this site for updates as we continue to treat more patients.